MARKET

PAVMZ

Pavmed Inc
PAVMZ
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.0014
0.0034
-0.0040
-
PAVMED INC <PAVM.O>: ASCENDIANT CAPITAL MARKETS CUTS TARGET PRICE TO $17 FROM $20
Reuters · 12/10 08:33
PAVmed Shareholders Approve Reverse Stock Split and Share Reduction
Reuters · 12/05 21:16
PAVMED INC - QTRLY SHR LOSS $0.29
Reuters · 11/12 22:36
PAVmed Inc. to Report Third Quarter 2025 Financial Results
Reuters · 10/30 12:03
Lucid Diagnostics Inc. Files Initial Beneficial Ownership Statement for Director John R. Palumbo
Reuters · 10/07 20:46
PAVmed Subsidiary Veris Health Launches Commercial Phase of Strategic Partnership with Ohio State University Comprehensive Cancer Center
Reuters · 10/07 12:03
PAVMED SUBSIDIARY, VERIS HEALTH AND THE OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER LAUNCH COMMERCIAL PHASE OF STRATEGIC PARTNERSHIP AGREEMENT
Reuters · 10/07 12:02
Lucid Diagnostics Inc. Files Prospectus Supplement for Common Stock Offering, Raising Approximately $26.9 Million
Reuters · 09/11 13:28
More

Webull offers Pavmed Inc stock information, including NASDAQ: PAVMZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PAVMZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PAVMZ stock methods without spending real money on the virtual paper trading platform.